ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/09/2022
Voltar para busca
Dado oficial do USPTO
SUMITOVANT BIOPHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SUMITOVANT BIOPHARMA
ST13
US500000079283146Classe
5, 9, 35, 42, 44
Pedido
79283146
Registro
6564625
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
09/09/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 35, 42, 44
Data de depósito
27/12/2019
Data de registro
23/11/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/11/2021
Última transação
23/11/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
JP
Examinador
ELTON, DAVID JONATHAN
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Sumitomo Pharma Co., Ltd.
Sumitomo Dainippon Pharma Co., Ltd.
Representantes
Jeffrey Costellia NIXON PEABODY LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparationsanti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the central nervous systemperipheral nervous systemcardiovascular systemendocrine systemmetabolic systemrenal systemgastroenterological systemophthalmologic system; pharmaceutical preparations for the prevention and treatment of hematologic and oncologic disorders and diseasespsychiatric disorders and diseasesallergic disorders and diseases and disorders and diseases of the immune systemconnective tissue and joints; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparation for use in chemotherapy; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the urogenital system; pharmaceutical preparations for the prevention and treatment of disorders and diseases of the dermatologic system; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for hereditary diseases; pharmaceutical diagnostic preparations for medical purposes; pharmaceutical diagnostic reagents for medical use; biologic preparations for medical and therapeutic purposesvaccines; biologic preparations for medical and therapeutic purposescells for medical or clinical use; biologic preparations for medical and therapeutic purposesnucleic acid sequences for medical purposes
Classe 9
Calculating machines; data processing apparatus; computers; computer hardware; computer peripherals; Downloadable computer software for providinganalyzing and generating reports; downloadable computer software and programs for the capturecollectionconversionanalysiscommunicationprocessingreceivingrecordingstorage and/or transmission of dataimages and information; downloadable computer software and programs for the conversionanalysisprocessingstorage and transmission of artificial intelligence; downloadable computer software for database integration; downloadable computer software for creating searchable databases of information and data; downloadable computer software featuring electronic computer databases in the field of pharmaceuticals and medical information; downloadable computer software for management of medical practices and research; downloadable computer search engine software for accessing and providing updated scientificmedicalpharmaceutical and clinical informationnews information of general interest; downloadable computer software for accessingcontrolling and managing data and information related to healthcare services and patient medical information; downloadable computer software for measuringmonitoringprocessing and tracking healthwellness and medical information; downloadable computer software for use with medical patient monitoring equipmentfor receivingprocessingtransmitting and displaying data; downloadable computer software for analytics in the fields of public healthhealthcarebiomedical research; downloadable computer software for analytics for clinical trial data
Classe 35
Advertising; publicity agency services; business management; business management assistance; business administration; business consulting services; secretarial services; providing office functions; business research; providing business information; marketing research; market analysis services; provision of market research information; marketing services; compiling of information into computer databases; updating and maintenance of data in computer databases; business data analysis; assistanceadvisory services and consultancy with regard to business analysisin the field of healthcarebiomedical and pharmaceutical research and pharmaceutical preparations; statistical analysis; statistical analysis and reporting in the field of healthcarebiomedical and pharmaceutical research and pharmaceutical preparations; statistical analysis and reporting services for business purposes in the fields of healthcare databiomedical and pharmaceutical research and clinical trial data; business analysis in the field of healthcarebiomedical and pharmaceutical research and pharmaceutical preparations; systematization of data in computer databases
Classe 42
technical consultancy relating to technical and scientific analysis in the fields of healthcarebiomedical and pharmaceutical research and pharmaceutical preparations; medical research; chemistry servicesresearch in the field of chemistry; clinical trialsconducting clinical trials for others; analysis of technical datadata analytics in the fields of pharmaceutical and biomedical research and developmentclinical trialsthe provision of medical and healthcare services; testinginspection or scientific research of pharmaceuticalscosmetics or foodstuffs; providing medical and scientific research information relating to clinical trials of pharmaceuticals; medical and scientific research in the field of pharmaceutical and biologic therapeutic products; providing information relating to testinginspection or medical and scientific research of pharmaceuticals; cloud computing featuring software for use in database management in the field of healthcarepharmaceuticalsbiomedicineclinical trialpost-market trial data; provision of scientific and technological information and data relating to scientific and technological research and development in the fields of healthcarebiomedical and pharmaceutical research and pharmaceutical preparations; rental of computers; providing temporary use of online non-downloadable computer programs on data networks containing databases of pharmaceutical productsmedical informationclinical trial data as well as data from post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; software as a service SaaS featuring software for providing information online in the fields of biomedical research and clinical trials from a computer database or the Internet; computer software designcomputer programmingmaintenance of computer software
Classe 44
Provision of medical information; providing health information; providing medical information from a web site; providing healthcare information from a web site; health counseling; provision of medical information relating to pharmaceutical and biologic therapeutic products
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
30/05/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/05/2022
FIMP
FINAL DISPOSITION PROCESSED
10/05/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
23/02/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
23/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/09/2021
PUBO
PUBLISHED FOR OPPOSITION
07/09/2021
GPNX
NOTIFICATION PROCESSED BY IB
05/09/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/08/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
18/08/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/08/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/07/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
30/07/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
30/07/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
30/07/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
30/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/07/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
13/07/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/03/2021
GNFR
FINAL REFUSAL E-MAILED
10/03/2021
CNFR
FINAL REFUSAL WRITTEN
10/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/02/2021
ALIE
ASSIGNED TO LIE
03/02/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/10/2020
ATRV
ATTORNEY REVIEW COMPLETED
08/07/2020
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
01/07/2020
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
26/06/2020
RFNT
REFUSAL PROCESSED BY IB
15/05/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
28/04/2020
RFRR
REFUSAL PROCESSED BY MPU
28/04/2020
MAFR
APPLICATION FILING RECEIPT MAILED
17/04/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/04/2020
CNRT
NON-FINAL ACTION WRITTEN
14/04/2020
DOCK
ASSIGNED TO EXAMINER
13/04/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/04/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/04/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SUMITOVANT BIOPHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.